New Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 6111901 | UNC2541 | 1612782-86-1 | 98% Min. |  |
| UNC2541 is a potent and MerTK-specific inhibitor and exhibits sub-micro molar inhibit | ||||
| 204504 | Zegocractin ( CM-4620 ) | 1713240-67-5 | ≧98.0% | _1713240-67-5.png) |
| Zegocractin (CM-4620, Auxora(TM)) is a small-molecule inhibitor of the calcium releas | ||||
| 2091906 | BAY-2416964 | 2242464-44-2 | 98% Min. |  |
| BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 16122809 | Elacestrant | 722533-56-4 | ≧98.0% |  |
| Elacestrant, also known as RAD1901, is an orally available, selective estrogen recept | ||||
| 21922 | Difelikefalin HCl | 2413256-25-2 | ≧98.0% |  |
| Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is a novel and potent kappa opio | ||||
| 20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% |  |
| Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
| 20302 | VAS3947 | 869853-70-3 | ≧98.0% |  |
| VAS3947 is a selective inhibitor of NADPH oxidase activity in low micromolar concentr | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 822221 | IACS-13909 | 2160546-07-4 | ≧98.0% |  |
| IACS-13909 is a specific and potent allosteric inhibitor of SHP2, that suppresses sig | ||||